Figure 1From: Investigation of utilization of nanosuspension formulation to enhance exposure of 1,3-dicyclohexylurea in rats: Preparation for PK/PD study via subcutaneous route of nanosuspension drug delivery DCU particle size analysis. Regular suspension (top) and nanosuspension (bottom).Back to article page